» Articles » PMID: 34880258

Deep Nasal Sinus Cavity Microbiota Dysbiosis in Parkinson's Disease

Overview
Date 2021 Dec 9
PMID 34880258
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Olfactory dysfunction is a pre-motor symptom of Parkinson's disease (PD) that appears years prior to diagnosis and can affect quality of life in PD. Changes in microbiota community in deep nasal cavity near the olfactory bulb may trigger the olfactory bulb-mediated neuroinflammatory cascade and eventual dopamine loss in PD. To determine if the deep nasal cavity microbiota of PD is significantly altered in comparison to healthy controls, we characterized the microbiota of the deep nasal cavity using 16S rRNA gene amplicon sequencing in PD subjects and compared it to that of spousal and non-spousal healthy controls. Correlations between microbial taxa and PD symptom severity were also explored. Olfactory microbial communities of PD individuals were more similar to those of their spousal controls than to non-household controls. In direct comparison of PD and spousal controls and of PD and non-spousal controls, significantly differently abundant taxa were identified, and this included increased relative abundance of putative opportunistic-pathobiont species such as Moraxella catarrhalis. M. catarrhalis was also significantly correlated with more severe motor scores in PD subjects. This proof-of-concept study provides evidence that potential pathobionts are detected in the olfactory bulb and that a subset of changes in the PD microbiota community could be a consequence of unique environmental factors associated with PD living. We hypothesize that an altered deep nasal microbiota, characterized by a putative pro-inflammatory microbial community, could trigger neuroinflammation in PD.

Citing Articles

Microbiota Orchestra in Parkinson's Disease: The Nasal and Oral Maestros.

Rei N, Grunho M, Mendes J, Fonseca J Biomedicines. 2024; 12(11).

PMID: 39594984 PMC: 11591639. DOI: 10.3390/biomedicines12112417.


Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota.

Ran Z, Mu B, Wang D, Xin-Huang , Ma Q, Lu M Mol Neurobiol. 2024; 62(4):5273-5296.

PMID: 39531191 DOI: 10.1007/s12035-024-04584-9.


Gut microbiota dysbiosis and neurologic diseases: New Horizon with potential diagnostic and therapeutic impact.

Keshavarzian A, Sisodia S Neurotherapeutics. 2024; 21(6):e00478.

PMID: 39488472 PMC: 11585866. DOI: 10.1016/j.neurot.2024.e00478.


Multi-amplicon microbiome data analysis pipelines for mixed orientation sequences using QIIME2: Assessing reference database, variable region and pre-processing bias in classification of mock bacterial community samples.

Maki K, Wolff B, Varuzza L, Green S, Barb J PLoS One. 2023; 18(1):e0280293.

PMID: 36638095 PMC: 9838852. DOI: 10.1371/journal.pone.0280293.


Deleterious Effect of Air Pollution on Human Microbial Community and Bacterial Flora: A Short Review.

Gupta N, Yadav V, Gacem A, Al-Dossari M, Yadav K, Abd El-Gawaad N Int J Environ Res Public Health. 2022; 19(23).

PMID: 36497569 PMC: 9738139. DOI: 10.3390/ijerph192315494.


References
1.
Unger M, Spiegel J, Dillmann K, Grundmann D, Philippeit H, Burmann J . Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat Disord. 2016; 32:66-72. DOI: 10.1016/j.parkreldis.2016.08.019. View

2.
Callahan B, McMurdie P, Rosen M, Han A, Johnson A, Holmes S . DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016; 13(7):581-3. PMC: 4927377. DOI: 10.1038/nmeth.3869. View

3.
Kelly B, Gross R, Bittinger K, Sherrill-Mix S, Lewis J, Collman R . Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics. 2015; 31(15):2461-8. PMC: 4514928. DOI: 10.1093/bioinformatics/btv183. View

4.
Davis N, Proctor D, Holmes S, Relman D, Callahan B . Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018; 6(1):226. PMC: 6298009. DOI: 10.1186/s40168-018-0605-2. View

5.
Hawkes C, Del Tredici K, Braak H . Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007; 33(6):599-614. PMC: 7194308. DOI: 10.1111/j.1365-2990.2007.00874.x. View